Cargando…
The changing face of clinical trials in the personalized medicine and immuno-oncology era: report from the international congress on clinical trials in Oncology & Hemato-Oncology (ICTO 2017)
In the past decade, the oncology community has witnessed major advances in the understanding of cancer biology and major breakthroughs in several different therapeutic areas, from solid tumors to hematological malignancies; moreover, the advent of effective immunotherapy approaches, such as immune-c...
Autores principales: | Golan, Talia, Milella, Michele, Ackerstein, Aliza, Berger, Ranaan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5745625/ https://www.ncbi.nlm.nih.gov/pubmed/29282151 http://dx.doi.org/10.1186/s13046-017-0668-0 |
Ejemplares similares
-
Stem Cells in Hemato-Oncology
por: Damodar, S
Publicado: (2006) -
Roadbook for the implementation of next-generation sequencing in clinical practice in oncology and hemato-oncology in Belgium
por: Van Valckenborgh, Els, et al.
Publicado: (2018) -
Monitoring of the Environment at the Transplant Unit—Hemato-Oncology Clinic
por: Matoušková, Ivanka, et al.
Publicado: (2014) -
The Role of Radiation Oncology in Immuno‐Oncology
por: Meng, Xiangjiao, et al.
Publicado: (2019) -
Immuno-Oncology
por: Chaudhuri, Swapna
Publicado: (2017)